Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

MCC Update 07-02-13

AHCMCC2 - Image - 560x80 - Update banner

Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, sherm019@umn.edu, by noon on Friday for publication the following Tuesday.

NOTE: Update will be published bi-weekly beginning with this issue. Weekly publication will resume on September 10, 2013.

 

July 2, 2013

 

In This Issue

 

News

Clinical Trials

Professional Education

Events

Funding Opportunities

Position Available


 

News  

Members in the news

Jonathan Sachs, Ph.D., and Cancer Biology Training Grant postdoctoral fellow Casey Dorr, Ph.D., were quoted in a Star Tribune story on the impact of budget cuts on medical research. Read more.

Jaime Modiano, V.M.D, Ph.D., Genetic Mechanis is featured in the Spring 2013 Legacy magazine of the University of Minnesota Foundation. Read more.

Jakub Tolar, M.D., Ph.D., Transplant Biology and Therapy Program, spoke with WCCO Radio's Jordana Green Show about the implications of the Supreme Court’s decision to ban patents on isolated human genes.

Members receive grants
Ameeta Kelekar, Ph.D., Cell Signaling Program, was awarded a Pilot/Feasibility (P/F) Grant through the NIH Common Fund’s Metabolomics initiative for promoting biological and clinical application of metabolomics technologies.  The one-year grant entitled “Glucose and ROS responsive metabolic regulators in primary and leukemic T cells” will utilize the NIH funded “Regional Comprehensive Metabolomics Resource Core” (RCMRC) at Michigan for the proposed research.

MCC researchers receive Research Infrastructure Investment awards
The Office of the Vice President for Research announced the recipients of 2013 Research Infrastructure Investment awards. The goal of the awards is to facilitate interdisciplinary collaborations that strengthen the university’s research infrastructure. This program is a joint initiative of President’s Office, the Office of the Vice-President for Research, and university colleges. Read more.

Ten projects were funded. Masonic Cancer Center members are involved in the following:

  • Establishing Mass Cytometry at the University of Minnesota
  • Single-cell Genomics Instrumentation
  • Dedicated University of Minnesota Research Resource at the Minnesota State Fair
  • A High Resolution Mass Spectrometry System for Interdisciplinary Metabolomics Research
  • A Bio-repository to Support Interdisciplinary Research at the University of Minnesota
  • A Fast, Accurate and Automated Solution for Correlative Light and Electron Microscopy

U celebrates grand opening of Cancer and Cardiovascular Building
The University of Minnesota celebrated the grand opening of the Cancer and Cardiovascular Research Building on June 14. View a slide show and a video.

Kudos
Congratulations to Masonic Cancer Center member Daniel Weisdorf, M.D., on his recent appointment at Director of the Division of Hematology, Oncology and Transplantation in the Department of Medicine.

Back to top

Clinical Trials

The following clinical trials conducted by Masonic Cancer Center members were recently opened:

2012IS062
An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
PI: Jha, Gautam

For more information on clinical trials contact Marva Bohen,  R.N., B.S.N. (ccinfo@umn.edu,  612-624-2620).

Back to top

Professional Education

July 2, 2013: Breast Cancer Journal Club
2-3 p.m., 441 MCRB
Aleks Ochnik will discuss "GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression" by Chou et al. in Nat Cell Biol. 2013 Feb;15(2):201-13.

September 16, 2013: 10th Annual Women’s Health Research Conference – “Optimizing Women’s Health Through a Life Course Approach”
McNamara Alumni Center, 200 Oak St, Minneapolis, Minn.
Keynote Speakers:
Paula Braveman, M.D., M.P.H., Professor, Family and Community Medicine, University of California-San Francisco
Janet Rich-Edwards, ScD, M.P.H., Investigator, Nurses’ Health Study, Harvard School of Public Health

To register visit the website.

September 26-27, 2013: The Second Minnesota Neuro-Oncology Symposium: Basic Discovery Accelerating Groundbreaking Brain Tumor Therapy
McNamara Alumni Center, 200 Oak Street SE, Minneapolis, Minn.
Presented by: The Brain Tumor Program, Masonic Cancer Center, University of Minnesota, University of Minnesota Medical Center, Fairview, University of Minnesota Amplatz Children’s Hospital

For more information and to register visit the website.

Visit the Education and Training Opportunities web page for more conference and special lecture listings.

Back to top

Events 

July 22, 2013: Rein in Sarcoma Party in the Park
Cafesjian’s Carousel and Como Park Visitor Center, St. Paul, Minn.
This annual event, hosted by the Karen Wyckoff Rein in Sarcoma Foundation, benefits sarcoma research at the Masonic Cancer Center, University of Minnesota. Join us as we celebrate the 13th anniversary of this event with a magical evening of music, entertainment, and family fun. Visit www.reininsarcoma.org.

September 7, 2013: HOM Silent No More Walk/Run for Ovarian Cancer
Rosland Park, Edina

September 18, 2013: Save the Date for Varsity Team Rally III!
6-9 p.m., Cancer/Cardiovascular Building, Biomedical Discovery District

Visit the Community Events and Outreach page for more information.

Back to top

Funding Opportunities

Prostate Cancer Research Program (PCRP)
Sponsor:
Department of Defense
Deadlines: Various; see announcements
Funding: See announcements

Peer Reviewed Medical Research Program (PRMRP)
Discovery Award
Sponsor:
Department of Defense
Deadline: Letter of Intent: July 23, 2013; Application: August 6, 2013
Funding: $125,000 plus indirect costs for up to 18 months

The CTRS Mini Pilot Funding Program
Sponsor: Clinical and Translational Research Institute
Deadline: Letter of Intent: July 15, 2013, 5 p.m.; full proposal: August 26, 2013
Funding: Up to $5,000 for one year.
The CTRS Mini Pilot Funding Program is designed to assist UMN faculty members in developing preliminary data for promising and innovative research projects.  This mini pilot funding opportunity is awarded with the expectation that preliminary and exploratory data will be collected and used within a larger research project proposal for application of additional future external funding and publications. All University of Minnesota full-time faculty with the rank of Associate (both tenure and non-tenure track), Assistant Professor (both tenure and non-tenure track), or Research Associates at any campus (Twin Cities, Rochester, Duluth, Morris, and Crookston) are eligible to apply as Principal Investigator. All applicants must be without NIH funding, with the exception of NIH training grants.   Assistant and Associate Professors who have other sources of extramural funding (federal or nonfederal) looking to explore a new area of inquiry are also welcome to apply. Mini awards up to $5,000 of clinical research support services through CTSI will be awarded on a continuous basis.  Click here to learn more and apply.

Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.

Back to top

Postdoctoral Position Available

A postdoctoral position is immediately available in the Hackel lab at the University of Minnesota. Our laboratory is located in the Department of Chemical Engineering and Materials Science. We apply protein engineering technologies to develop in vivo molecular imaging agents for the early detection and molecular characterization of cancer as well as targeted therapies. The laboratory is a balance of (1) fundamental study of molecular evolution and protein biophysics, which empowers our protein engineering efforts; (2) in vivo study of physiological distribution of protein ligands, which guides improved delivery of molecular imaging agents as well as therapies; and (3) application of advances in these aims towards clinical challenges in the detection, characterization, and treatment of cancer.  

Postdoctoral positions are available in protein engineering, delivery, and development of molecular imaging agents. We seek a motivated researcher with a Ph.D. in any related discipline as we value the diverse perspectives and expertise of an interdisciplinary environment. Experience in molecular biology, protein chemistry, or small animal imaging are beneficial. Please send a brief description of your career goals, your curriculum vitae, and contact information for three references to hackel@umn.edu.

For more information, please visit http://research.cems.umn.edu/hackel.

Back to top

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on July 15, 2013